Importantly, we found that PRKDC could inhibit the tumor-suppressive function of ZBTB38, as PRKDC knockdown (Supplementary Fig. 2C) resulted in the increase of DKK1 expression and enhanced the tumor-suppressive function of ZBTB38 (Fig. 5C–F). Here, PRKDC is linked to neoplasm.